Karuna Therapeutics’ schizophrenia drug passes Phase II trial

Schizophrenia is a chronic, disabling mental disorder that causes recurring episodes of psychosis. Credit: Pete Linforth from Pixabay.



  • Karuna Therapeutics schizophrenia drug passes Phase II trial